Guidance for Industry on Tropical Disease Priority Review Vouchers

ICR 201511-0910-002

OMB: 0910-0822

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2016-07-15
ICR Details
0910-0822 201511-0910-002
Historical Active
HHS/FDA CDER
Guidance for Industry on Tropical Disease Priority Review Vouchers
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 08/01/2016
Retrieve Notice of Action (NOA) 11/20/2015
  Inventory as of this Action Requested Previously Approved
08/31/2019 36 Months From Approved
14 0 0
112 0 0
0 0 0

Section 524 of the Federal Food, Drug, and Cosmetic Act makes provisions for awarding priority review vouchers for future applications to sponsors of tropical disease product applications that meet the criteria specified by the Act. The guidance explains to internal and external stakeholders how FDA intends to implement the provisions of section 524.

US Code: 21 USC 524 Name of Law: FDAAA
  
None

Not associated with rulemaking

  73 FR 62298 10/20/2008
80 FR 72068 11/18/2015
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 14 0 0 14 0 0
Annual Time Burden (Hours) 112 0 0 112 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a new data collection.

$7,508
No
No
No
No
No
Uncollected
Ila Mizrachi 301 796-7726 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/20/2015


© 2024 OMB.report | Privacy Policy